Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEuropean Metals Holdings Regulatory News (EMH)

If you are a professional, HNW or sophisticated investor and want to learn more about the current funding round for Peloton Minerals, please email kat.perez@focusir.com.

Share Price Information for European Metals Holdings (EMH)

Share Price is delayed by 15 minutes
Get Live Data
14.50    -0.75 (-4.92%)
Bid:
14.00
Ask:
15.00
Spread: 1.00 (7.143%)
Market Cap: £34.45m
EMH Live PriceLast checked at - London Stock Exchange

Intraday European Metals Holdings Share Chart

Half-year Report

16 Mar 2022 08:26

RNS Number : 9560E
European Metals Holdings Limited
16 March 2022
 

16 March 2022

 

INTERIM FINANCIAL REPORTFor the six months ended 31 December 2021

 

The Directors of European Metals Holdings Limited ("European Metals" or "the Company") (ASX & AIM: EMH), the specialty lithium exploration and development company with assets in the Czech Republic is pleased to advise all shareholders and interested investors of the release of the Company's interim financial results for the half year ended 31 December 2021. The full interim financial report is available here: https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02500058-6A1082233?access_token=83ff96335c2d45a094df02a206a39ff4

A copy of the European Metals Half Year Report is also available on the Company's website at www. https://www.europeanmet.com/company-reports/.

CONTACT

For further information on this update or the Company generally, please visit our website at www.europeanmet.com or see full contact details at the end of this release.

 

WEBSITE

A copy of this announcement is available from the Company's website at www.europeanmet.com.

ENQUIRIES:

European Metals Holdings Limited

Keith Coughlan, Executive Chairman

 

 

Kiran Morzaria, Non-Executive Director

 

Dennis Wilkins, Company Secretary

 

Tel: +61 (0) 419 996 333

Email: keith@europeanmet.com

 

Tel: +44 (0) 20 7440 0647

 

Tel: +61 (0) 417 945 049

Email: dennis@europeanmet.com

 

WH Ireland (Nomad & Broker)

James Joyce/Darshan Patel (Corporate Finance)

Harry Ansell (Corporate Broking)

 

Tel: +44 (0) 20 7220 1666

Shard Capital (Joint Broker)

Damon Heath

Erik Woolgar 

 

Tel: +44 (0) 20 7186 9950

Blytheweigh (Financial PR)

Tim Blythe

Megan Ray

 

Tel: +44 (0) 20 7138 3222

Chapter 1 Advisors (Financial PR - Aus)

David Tasker

 

Tel: +61 (0) 433 112 936

 

The information contained within this announcement is considered to be inside information, for the purposes of Article 7 of EU Regulation 596/2014, prior to its release. The person who authorised for the release of this announcement on behalf of the Company was Keith Coughlan, Executive Chairman.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCZZGMFRVFGZZG
Date   Source Headline
27th May 20217:00 amRNSAddendum to previous release 19 May 2021
19th May 20218:35 amRNSSTRONG RESULTS FROM LOCKED-CYCLE TESTS
11th May 20219:37 amRNSIssue of Equity
10th May 20217:00 amRNSAdoption of ESG Standards
6th May 20218:05 amRNSChange of Registered Office
6th May 20218:03 amRNSEIA AND MEASURED RESOURCE DRILLING UPDATE
30th Apr 202111:04 amRNSQuarterly Report
16th Mar 202111:48 amRNSHalf-year Report
15th Mar 202110:12 amRNSForm TR-1 Notification
5th Mar 20217:00 amRNSIssue of Equity
9th Feb 20219:05 amRNSSecond Price Monitoring Extn
9th Feb 20219:00 amRNSPrice Monitoring Extension
8th Feb 20217:00 amRNSIssue of Equity - Expected Date of Admission
3rd Feb 20219:05 amRNSSecond Price Monitoring Extn
3rd Feb 20219:00 amRNSPrice Monitoring Extension
3rd Feb 20217:00 amRNSIssue of Equity
2nd Feb 20217:00 amRNSDrilling Report
1st Feb 20217:00 amRNSQuarterly Activities and Cashflow report
27th Jan 20212:34 pmRNSForm TR1
21st Jan 20214:41 pmRNSSecond Price Monitoring Extn
21st Jan 20214:36 pmRNSPrice Monitoring Extension
21st Jan 20212:05 pmRNSSecond Price Monitoring Extn
21st Jan 20212:00 pmRNSPrice Monitoring Extension
18th Jan 20211:36 pmRNSIssue of Equity
12th Jan 20211:22 pmRNSDirector/PDMR Shareholding
8th Jan 20214:40 pmRNSSecond Price Monitoring Extn
8th Jan 20214:36 pmRNSPrice Monitoring Extension
6th Jan 20218:40 amRNSIssue of Equity
4th Jan 20218:35 amRNSDirectorate Change and Change of Adviser
30th Dec 20209:47 amRNSFurther Funding Agreement
30th Dec 20207:00 amRNSForm TR1
30th Dec 20207:00 amRNSIssue of Equity
24th Dec 202012:40 pmRNSSecond Price Monitoring Extn
24th Dec 202012:35 pmRNSPrice Monitoring Extension
22nd Dec 20208:13 amRNSIssue of Equity
18th Dec 20207:16 amRNSResult of AGM
15th Dec 20202:06 pmRNSSecond Price Monitoring Extn
15th Dec 20202:00 pmRNSPrice Monitoring Extension
15th Dec 20201:35 pmRNSNasdaq Quotation
7th Dec 20201:16 pmRNSAddendum to Notice of AGM
30th Nov 20201:19 pmRNSNotice of AGM
25th Nov 202012:14 pmRNSIssue of Equity
16th Nov 20201:44 pmRNSIssue of Equity
9th Nov 20202:36 pmRNSStatement re ASX share price query
6th Nov 20204:40 pmRNSSecond Price Monitoring Extn
6th Nov 20204:35 pmRNSPrice Monitoring Extension
6th Nov 20207:31 amRNSIncrease Access for US Investment with OTC Listing
5th Nov 20202:05 pmRNSSecond Price Monitoring Extn
5th Nov 20202:00 pmRNSPrice Monitoring Extension
5th Nov 20209:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.